ADAPTIN BIO, INC.Amended

Biotechnology · CHARLOTTE, NC

BiotechnologySEC Form D

ADAPTIN BIO, INC. filed a Form D with the U.S. Securities and Exchange Commission on March 23, 2026, reporting $1,652,000 raised toward a $4,000,000 offering.

Incorporated in Delaware and based in CHARLOTTE, NC, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that ADAPTIN BIO, INC. has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Michael RobertsExecutive Officer · Director
  • Patrick GallagherDirector
  • J. Nick RiehleDirector
  • Anthony ZookDirector
  • L. Arthur HewittExecutive Officer
  • Timothy ManessExecutive Officer
  • Simon PedderExecutive Officer · Director

Recently funded in Biotechnology

Other companies that recently filed a Form D

$3.2MRaised

Goldenrod Therapeutics, Inc.

BiotechnologyHOUSTON, TX
May 26, 2026View SEC Form D
$10.0MRaised

Human Biotech, Inc.

BiotechnologyCAMBRIDGE, MA
May 22, 2026View SEC Form D
$1.0MRaised

Optimeos Life Sciences, Inc.

BiotechnologyPRINCETON, NJ
May 22, 2026View SEC Form D
$2.5MRaised

BioStem Technologies, Inc.

BiotechnologyPOMPANO BEACH, FL
May 21, 2026View SEC Form D
$1.6MRaised

Biolexis Therapeutics Inc.

BiotechnologyLEHI, UT
May 20, 2026View SEC Form D
ADAPTIN BIO, INC. raised $1.7M — SEC Form D